The Food and Drug Administration (FDA) is seeking public comments on the proposed collection of information related to exports of products such as drugs, biologics, and medical devices that are not sold in the U.S. This request is part of the requirements under the Paperwork Reduction Act of 1995, and comments are due by June 30, 2025. The goal is to collect opinions on whether the information collection is necessary, its accuracy, and ways to reduce the burden on respondents. The notification and recordkeeping requirements mostly apply to exporters who must follow specific guidelines to ensure their products meet the standards of the destination countries.
Simple Explanation
The FDA wants people to share their thoughts on the rules about sending products like medicine and medical devices to other countries, and they want people to tell them if these rules are too hard to follow or need to change.